InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Explore the complete record of transactions filed by Fruchtman Steven M, 首席执行官. Insider active across 1 company, notably Onconova Therapeutics, Inc.. Cumulatively, 6 reports have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €9k. History available since 28 September 2021. The latest transaction was filed on 28 September 2021 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Fruchtman Steven M
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
23,111 股Common StockSEC:0001415889-24-008141:0
21,320 股Common StockSEC:0001415889-24-003204:0
12,567 股Common StockSEC:0001415889-23-011866:0
21,320 股Common StockSEC:0001415889-23-002171:0
12,566 股Common StockSEC:0001415889-22-008258:0
2,381 股@ US$4.20100.0% 占其流量Common StockSEC:0001179110-21-008956:0
标准退出：2021年12月27日 (T+90)
6 条申报中的 6 条
About Fruchtman Steven M
Steven M Fruchtman is the President and Chief Executive Officer of Onconova Therapeutics, Inc. He is responsible for the strategic direction of the company, overseeing operations and development initiatives. His expertise in the biopharmaceutical sector is essential for guiding the company's growth and innovation.
